A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

Cites (297)

Items 201–297 of 297

1. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease
   Nicholas H. Varvel, Kiran Bhaskar, Maria Z. Kounnas, Steven L. Wagner, Yan Yang, Bruce T. Lamb, Karl Herrup · 2009 · Journal of Clinical Investigation
2. PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
   Harald Juergen Hampel, Sid E. O’Bryant, Juan Ignacio Castrillo, Craig William Ritchie, Katrine Rojkova, Karl Broich, Norbert Benda, Robert Nisticò, Richard Frank, Bruno Dubois et al. · 2016 · The Journal of Prevention of Alzheimer s Disease
3. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
   Kunal Dhiman, Kaj Blennow, Henrik Zetterberg, Ralph Nigel Martins, Veer Bala Gupta · 2019 · Cellular and Molecular Life Sciences
4. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection
   Filippo Caraci, Simona Federica Spampinato, Maria Angela Sortino, Paolo Bosco, Giuseppe Battaglia, Valeria Bruno, Filippo Drago, Ferdinando Nicoletti, Agata Copani · 2011 · Cell and Tissue Research
5. Results of a follow‐up study to the randomized Alzheimer's Disease Anti‐inflammatory Prevention Trial (ADAPT)
   The Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group · 2013 · Alzheimer s & Dementia
6. [ 11 C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
   Passamonti, Luca, Rodríguez, Patricia Vázquez, Hong, Young T., Allinson, Kieren S.J., Bevan-Jones, W. Richard, Williamson, David, Jones, P. Simon, Arnold, Robert, Borchert, Robin J., Surendranathan, Ajenthan et al. · 2018 · Neurology
7. Effect of aerobic exercise on physical performance in patients with Alzheimer's disease
   Nanna Aue Sobol, Kristine Hoffmann, Kristian Steen Frederiksen, Asmus Vogel, Karsten Vestergaard, Hans Brændgaard, Hanne Gottrup, Annette Lolk, Lene Wermuth, Søren Jakobsen et al. · 2016 · Alzheimer s & Dementia
8. Precision pharmacology for Alzheimer’s disease
   Harald Juergen Hampel, Andrea Vergallo, Lisi Flores Aguilar, Norbert Benda, Karl Broich, A. Claudio Cuello, Jeffrey L. Cummings, Bruno Dubois, Howard J. Federoff, Massimo S. Fiandaca et al. · 2018 · Pharmacological Research
9. Imaging of neuroinflammation in dementia: a review
   James D. Stefaniak, John Tiernan O'Brien · 2015 · Journal of Neurology Neurosurgery & Psychiatry
10. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
    Baldacci, Filippo, Lista, Simone, Cavedo, Enrica, Bonuccelli, Ubaldo, Hampel, Harald · 2017 · Expert Review of Proteomics
11. Absence of microglial CX3CR1 impairs the synaptic integration of adult-born hippocampal granule neurons
    Marta Bolós, Juan Ramón Perea, Julia Terreros‐Roncal, Noemí Pallas‐Bazarra, Jerónimo Jurado‐Arjona, Jesús Ávila, Marı́a Llorens-Martı́n · 2017 · Brain Behavior and Immunity
12. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
    Meyer, Pierre-François, Tremblay-Mercier, Jennifer, Leoutsakos, Jeannie, Madjar, Cécile, Lafaille-Maignan, Marie-Élyse, Savard, Melissa, Rosa-Neto, Pedro, Poirier, Judes, Etienne, Pierre, Breitner, John et al. · 2019 · Neurology
13. The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
    A. Claudio Cuello, Rowan Pentz, Hélène Hall · 2019 · Frontiers in Neuroscience
14. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice
    Nathaniel S. Woodling, Damien Colas, Qian Wang, Paras Singh Minhas, Maharshi Panchal, Xibin Liang, Siddhita D. Mhatre, Holden D. Brown, Novie Ko, Irene A. Zagol-Ikapitte et al. · 2016 · Brain
15. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques
    Yamaguchi, H., Sugihara, Shiro, Ogawa, Akira, Saido, Takaomi C., Ihara, Yasuo · 1998 · Acta Neuropathologica
16. Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [ 18 F]-FEPPA and Positron Emission Tomography
    Pablo Rusjan, Alan A. Wilson, Peter Michael Bloomfield, Irina Vitcu, Jeffrey H. Meyer, Sylvain Houle, Romina Mizrahi · 2011 · Journal of Cerebral Blood Flow & Metabolism
17. Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders
    Caruso, Giuseppe, Caraci, Filippo, Jolivet, Renaud B. · 2019 · Progress in Neurobiology
18. The Alzheimer Precision Medicine Initiative
    Harald Juergen Hampel, Alzheimer Precision Medicine Initiative, Andrea Vergallo, George L. Perry, Simone Lista · 2019 · Journal of Alzheimer s Disease
19. Microglia in Alzheimer’s disease: A target for immunotherapy
    Shoutang Wang, Marco Colonna · 2019 · Journal of Leukocyte Biology
20. Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity
    Adele J. Vincent, Robert Gasperini, Lisa C Foa, David Henry Small · 2010 · Journal of Alzheimer s Disease
21. Immune biomarkers: the promises and pitfalls of personalized medicine
    Joanna Willis, Graham M. Lord · 2015 · Nature reviews. Immunology
22. Neuroinflammatory Cytokine Signaling and Alzheimer's Disease
    W. Sue T. Griffin · 2013 · New England Journal of Medicine
23. Randomized phase 2 trial of NP001, a novel immune regulator
    Robert G. Miller, Gilbert A. Block, Jonathan Katz, Richard J. Barohn, Vidhya Gopalakrishnan, Merit Cudkowicz, Jane R. Zhang, Michael S. McGrath, Elizabeth A. Ludington, Stan H. Appel et al. · 2015 · Neurology Neuroimmunology & Neuroinflammation
24. Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?
    Maria Teresa Ferretti, A. Claudio Cuello · 2011 · Current Alzheimer Research
25. TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
    Zheng, Honghua, Cheng, Baoying, Li, Yanfang, Li, Xin, Chen, Xiaofen, Zhang, Yun-wu · 2018 · Frontiers in Aging Neuroscience
26. Altered subcellular location of phosphorylated Smads in Alzheimer's disease
    Uwe Ueberham, Elke Ueberham, Hildegard Gruschka, Thomas Arendt · 2006 · European Journal of Neuroscience
27. Cytokine expression and microglial activation in progressive supranuclear palsy
    Fernández-Botrán, Rafael, Ahmed, Zeshan, Crespo, Fabián A., Gatenbee, Chandler, Gonzalez, John, Dickson, Dennis W., Litvan, Irene · 2011 · Parkinsonism & Related Disorders
28. Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease
    Rathore, Nisha, Ramani, Sree Ranjani, Pantua, Homer, Payandeh, Jian, Bhangale, Tushar, Wuster, Arthur, Kapoor, Manav, Sun, Yonglian, Kapadia, Sharookh B., Gonzalez, Lino et al. · 2018 · PLOS Genetics
29. Transforming growth factor‐β stimulates β amyloid uptake by microglia through Smad3‐dependent mechanisms
    Juan Enrique Tichauer, Rommy von Bernhardi M. · 2012 · Journal of Neuroscience Research
30. Physical Exercise Improves Cognitive Function Together with Microglia Phenotype Modulation and Remyelination in Chronic Cerebral Hypoperfusion
    Ting Jiang, Liying Zhang, Xiaona Pan, Haiqing Zheng, Xi Chen, Lili Li, Jing Luo, Xiquan Hu · 2017 · Frontiers in Cellular Neuroscience
31. Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1
    Sebastiano Alfio Torrisi, Federica Geraci, Maria Rosaria Tropea, Margherita Grasso, Giuseppe Caruso, Annamaria Fidilio, Nicolò Musso, Giulia Sanfilippo, Fabio Tascedda, Agostino Palmeri et al. · 2019 · Frontiers in Pharmacology
32. Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues
    Sid E. O’Bryant, Guanghua Xiao, Fan Zhang, Melissa Edwards, Dwight C. German, Xiangling Yin, Tori Como, Joan Reisch, Ryan M. Huebinger, Neill R. Graff‐Radford et al. · 2014 · Journal of Alzheimer s Disease
33. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s disease
    Giuseppina Cantarella, Giulia Di Benedetto, Daniela Puzzo, Lucia Privitera, Carla Loreto, Salvatore Saccone, Salvatore Giunta, Agostino Palmeri, Renato Bernardini · 2014 · Brain
34. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
    M. Florencia Iulita, María Beatriz Bistué Millón, Rowan Pentz, Lisi Flores Aguilar, Sonia Do Carmo, Simon T. M. Allard, Bernadeta Michalski, Edward N. Wilson, Adriana Ducatenzeiler, Martin Alejandro Bruno et al. · 2017 · Neurobiology of Disease
35. Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimers Disease
    Greg M. Cole, Sally Ann Frautschy · 2010 · CNS & Neurological Disorders - Drug Targets
36. The Evolving Dialogue of Microglia and Neurons in Alzheimer’s Disease: Microglia as Necessary Transducers of Pathology
    Simon, E., Obst, J., Gomez-Nicola, D. · 2019 · Neuroscience
37. Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
    Hesse, Raphael, Wahler, Anke, Gummert, Pauline, Kirschmer, Stefanie, Otto, Markus, Tumani, Hayrettin, Lewerenz, Jan, Schnack, Cathrin, von Arnim, Christine A. F. · 2016 · BMC Neurology
38. Isolated Amyloid-β(1–42) Protofibrils, But Not Isolated Fibrils, Are Robust Stimulators of Microglia
    Geeta S. Paranjape, Lisa K. Gouwens, David C. Osborn, Michael R. Nichols · 2012 · ACS Chemical Neuroscience
39. Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model
    Cavanagh, Chelsea, Tse, Yiu Chung, Nguyen, Huy-Binh, Krantic, Slavica, Breitner, John C.S., Quirion, Remi, Wong, Tak Pan · 2016 · Neurobiology of Aging
40. Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
    Ian A. Clark, Craig Atwood, Richard L. Bowen, Gilberto Paz-Filho, Bryce Vissel · 2012 · Pharmacological Reviews
41. TREM2 regulates innate immunity in Alzheimer’s disease
    Li, Jiang-Tao, Zhang, Ying · 2018 · Journal of Neuroinflammation
42. P2Y4 Receptor-Mediated Pinocytosis Contributes to Amyloid Beta-Induced Self-Uptake by Microglia
    Li, Hui-quan, Chen, Cong, Dou, Ying, Wu, Hang-jun, Liu, Yi-jun, Lou, Hui-Fang, Zhang, Jian-min, Li, Xiao-ming, Wang, Hao, Duan, Shumin · 2013 · Molecular and Cellular Biology
43. The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
    Sofia Söllvander, Elisabeth Nikitidou, Linn Streubel-Gallasch, Marlena Zyśk, Linda Söderberg, Dag Sehlin, Lars Lannfelt, Anna Erlandsson · 2018 · Journal of Neuroinflammation
44. Modulation of Inflammation as a Way of Delaying Alzheimer's Disease Progression: The Diet's Role
    Rita Businaro, Mariangela Corsi, Rosa Asprino, Cherubino Di Lorenzo, Debra L. Laskin, Rosa Maria Corbo, Serafino Ricci, Alessandro Pinto · 2017 · Current Alzheimer Research
45. Phenotypic and functional differences between senescent and aged murine microglia
    Stojiljkovic, Milan R., Ain, Quratul, Bondeva, Tzvetanka, Heller, Regine, Schmeer, Christian, Witte, Otto W. · 2019 · Neurobiology of Aging
46. A roadmap towards personalized immunology
    Sylvie Delhalle, Sebastian F. N. Bode, Rudi Balling, Markus W. Ollert, Feng Q. HeFeng · 2018 · npj Systems Biology and Applications
47. The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
    Filippo Baldacci, Simone Lista, Giovanni Palermo, Filippo Sean Giorgi, Andrea Vergallo, Harald Juergen Hampel · 2019 · Expert Review of Proteomics
48. Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification
    Hampel, Harald, Vergallo, Andrea, Giorgi, Filippo Sean, Kim, Seung Hyun, Depypere, Herman, Graziani, Manuela, Saidi, Amira, Nisticò, Robert, Lista, Simone · 2018 · Frontiers in Neuroendocrinology
49. In Vivo PET Imaging Demonstrates Diminished Microglial Activation After Fingolimod Treatment in an Animal Model of Multiple Sclerosis
    L. Airas, A. Dickens, Petri Elo, Päivi Marjamäki, J. Johansson, O. Eskola, P. Jones, W. Trigg, O. Solin, M. Haaparanta-Solin et al. · 2015 · Journal of Nuclear Medicine
50. A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment
    Teresa Gómez‐Isla, Rafael Blesa, Merçé Boada, Jordi Clarimón, Teodoro del Ser, Gemma Domènech, José Manuel Ferro, Beatriz Gómez‐Ansón, José María Manubens, J. M. Martínez‐Lage et al. · 2008 · Alzheimer Disease & Associated Disorders
51. Role of Neuroinflammation in the Trajectory of Alzheimer’s Disease and in vivo Quantification Using PET
    Paul Edison, David James Brooks · 2018 · Journal of Alzheimer s Disease
52. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor
    Roger Slavik, Adrienne Müller Herde, Daniel Bieri, Markus Weber, Roger Schibli, Stefanie D. Krämer, Simon Mensah Ametamey, Linjing Mu · 2015 · European Journal of Medicinal Chemistry
53. The Effects of IL-1 Receptor Antagonist on Beta Amyloid Mediated Depression of LTP in the Rat CA1 in Vivo
    Schmid, Adrien W., Lynch, Marina A., Herron, Caroline E. · 2009 · Hippocampus
54. Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis
    Mahwesh Saleem, Nathan Herrmann, Walter Swardfager, Rebecca B. Eisen, Krista L. Lanctôt · 2015 · Journal of Alzheimer s Disease
55. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine
    Mia Yang Ang, Teck Yew Low, Pey Yee Lee, Wan Fahmi Wan Mohamad Nazarie, Victor Guryev, Rahman Jamal · 2019 · Clinica Chimica Acta
56. Cognitive and Cerebral Metabolic Effects of Celecoxib Versus Placebo in People With Age-Related Memory Loss: Randomized Controlled Study
    Gary W. Small, Prabha Siddarth, Daniel H.S. Silverman, Linda M. Ercoli, Karen J. Miller, Helen Lavretsky, Susan Y. Bookheimer, S.-C. Huang, Jorge R. Barrio, Michael E. Phelps · 2008 · American Journal of Geriatric Psychiatry
57. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer’s Disease Model Mice
    Miho Shukuri, Aya Mawatari, Masahiro Ohno, Masaaki Suzuki, Hisashi Doi, Yasuyoshi Watanabe, Hirotaka Onoe · 2015 · Journal of Nuclear Medicine
58. Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
    Juan Ramón Perea, Alberto Lleó, Daniel Andres Alcolea, Juan Fortea, Jesús Ávila, Marta Bolós · 2018 · Frontiers in Neuroscience
59. Icariin Attenuates M1 Activation of Microglia and Aβ Plaque Accumulation in the Hippocampus and Prefrontal Cortex by Up-Regulating PPARγ in Restraint/Isolation-Stressed APP/PS1 Mice
    Yihe Wang, Tianrui Zhu, Min Wang, Feng Zhang, Guitao Zhang, Jing Zhao, Yuanyuan Zhang, Erxi Wu, Xiaohong Li · 2019 · Frontiers in Neuroscience
60. Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease
    Daniah Shamim, Michael Chris Laskowski · 2017 · Journal of Central Nervous System Disease
61. Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
    Malú G. Tansey, McAlpine · 2008 · Journal of Inflammation Research
62. Inhibition of Soluble Tumor Necrosis Factor Ameliorates Synaptic Alterations and Ca2+ Dysregulation in Aged Rats
    Diana M. Sama, Hafiz Mohmmad Abdul, Jennifer L. Furman, Irina A. Artiushin, David E. Szymkowski, Stephen W. Scheff, Christopher Mark Norris · 2012 · PLoS ONE
63. Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway
    Perea, Juan Ramón, Ávila, Jesús, Bolós, Marta · 2018 · Experimental Neurology
64. TNF alpha inhibitors in Alzheimer's disease: A systematic review
    Justyna O. Ekert, Rebecca L. Gould, Gemma Reynolds, Robert J. Howard · 2018 · International Journal of Geriatric Psychiatry
65. A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease
    Sid E. O’Bryant, Fan Zhang, Leigh Ann Johnson, James Richard Hall, Melissa Edwards, Paula Grammas, Esther S. Oh, Constantine George Lyketsos, Robert A. Rissman · 2018 · Journal of Alzheimer s Disease
66. The involvement of cell cycle events in the pathogenesis of Alzheimer's disease
    Karl Herrup · 2010 · Alzheimer s Research & Therapy
67. PET of Glial Metabolism Using 2-18F-Fluoroacetate
    Jan Mařı́k, Annie K. Ogasawara, Baby Martin-McNulty, Jed Ross, Judith E. Flores, Herman S. Gill, Jeff N. Tinianow, Alexander N. Vanderbilt, Merry C. Nishimura, Franklin V. Peale Jr. et al. · 2009 · Journal of Nuclear Medicine
68. Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
    Harald Juergen Hampel, Edward J. Goetzl, Dimitrios Kapogiannis, Simone Lista, Andrea Vergallo · 2019 · Frontiers in Pharmacology
69. Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer’s disease
    Harald Juergen Hampel, Simone Lista, Christian Néri, Andrea Vergallo · 2019 · Progress in Neurobiology
70. Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis
    M. Florencia Iulita, Aravind Ganesh, Rowan Pentz, Lisi Flores Aguilar, Palma Gubert, Adriana Ducatenzeiler, Sharon Christie, Gordon Keith Wilcock, A. Claudio Cuello · 2019 · Journal of Alzheimer s Disease
71. Is astrocyte calcium signaling relevant for synaptic plasticity?
    Sârrah Ben Achour, Lorena Pont‐Lezica, Catherine Béchade, Olivier Pascual · 2010 · Neuron Glia Biology
72. Systems Biology Methods for Alzheimer’s Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials
    Juan Ignacio Castrillo, Simone Lista, Harald Juergen Hampel, Craig William Ritchie · 2018 · Methods in molecular biology
73. TNF deficiency causes alterations in the spatial organization of neurogenic zones and alters the number of microglia and neurons in the cerebral cortex
    Minna Yli-Karjanmaa, Kathrine Solevad Larsen, Christina Fenger, Lotte Kellemann Kristensen, Nellie Anne Martin, Peter Toft Jensen, Alexandre Breton, Lubov Nathanson, Pernille Vinther Nielsen, Minna Christiansen Lund et al. · 2019 · Brain Behavior and Immunity
74. Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer’s Disease
    Simone Lista, Zaven S. Khachaturian, Dan Rujescu, Francesco Garaci, Bruno Dubois, Harald Juergen Hampel · 2015 · Methods in molecular biology
75. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction
    Lampros Dimitrakopoulos, Ioannis Prassas, Eleftherios P. Diamandis, George S. Charames · 2017 · Critical Reviews in Clinical Laboratory Sciences
76. Inflammatory markers in Alzheimer's disease and mild cognitive impairment: A meta‐analysis and systematic review of 170 studies
    Xue‐Ning Shen, Li‐Dong Niu, Yan‐Jiang Wang, Xi‐Peng Cao, Qiang Liu, Lan Tan, Can Zhang, Jin‐Tai Yu · 2020 · Alzheimer s & Dementia
77. Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers
    Lisa K. Gouwens, Nyasha J. Makoni, Victoria A. Rogers, Michael R. Nichols · 2016 · Brain Research
78. Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer’s disease
    Claudio Babiloni, Giovanni Battista Frisoni, Claudio Del Percio, Orazio Oz. Zanetti, Cristina Bonomini, Emanuele Cassetta, Patrizio Pasqualetti, Carlo Miniussi, Mario De Rosas, Anna Antonia Valenzano et al. · 2009 · Clinical Neurophysiology
79. All-or-Nothing Type Biphasic Cytokine Production of Human Lymphocytes After Exposure to Alzheimer's β-Amyloid Peptide
    Antônio Lúcio Teixeira, Helton José Reis, Fernanda Matos Coelho, Daniel S. Carneiro, Mauro Martins Teixeira, Luciene Bruno Vieira, Marat A. Mukhamedyarov, Andrey Lvovich Zefirov, Zoltán Janka, András Palotás · 2008 · Biological Psychiatry
80. Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC)
    Zhen Yang, Yunlong Zan, Xiujuan Zheng, Wangxi Hai, Kewei Chen, Qiu Huang, Yuhong Xu, Jinliang Peng · 2015 · PLoS ONE
81. Regional Molecular Mapping of Primate Synapses during Normal Healthy Aging
    Laura C. Graham, Michael J. Naldrett, Steven G. Kohama, Colin Smith, Douglas J. Lamont, Barry W. McColl, Thomas Henry Gillingwater, Paul Skehel, Henryk F. Urbanski, Thomas M. Wishart · 2019 · Cell Reports
82. Principles for central nervous system inflammation research: A call for a consortium approach
    Joseph Rogers · 2018 · Alzheimer s & Dementia
83. A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
    Seung Hyun Kim, Min‐Young Noh, Hee-Jin Kim, Ki‐Wook Oh, Jinseok Park, Sang-Gon Lee, Yeonsil Moon, Young-Eun Kim, Jae Sung Bae, Hee Kyung Jin et al. · 2019 · Dementia and Neurocognitive Disorders
84. P4–029: Glutamate dysregulation in tau P301L mice
    Holly C. Hunsberger, Carolyn C. Rudy, Miranda Nicole Reed · 2013 · Alzheimer s & Dementia
85. A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome
    M. Florencia Iulita, Filippo Caraci, A. Claudio Cuello · 2016 · CNS & Neurological Disorders - Drug Targets
86. Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
    Harald Juergen Hampel, Andrea Vergallo, Mohammad Afshar, Leyla Akman-Anderson, Joaquı́n Arenas, Norbert Benda, Richard Batrla, Karl Broich, Filippo Caraci, A. Claudio Cuello et al. · 2019 · Dialogues in Clinical Neuroscience
87. NSAID Use and Incident Cognitive Impairment in a Population-based Cohort
    Margarete A. Wichmann, Karen J. Cruickshanks, Cynthia M. Carlsson, Rick J Chappell, Mary Fischer, Ronald Klein, Ronald Klein, Carla R. Schubert · 2015 · Alzheimer Disease & Associated Disorders
88. A Brief Synopsis on the Genetics of Alzheimer’s Disease
    Kamboh, M. Ilyas · 2018 · Current Genetic Medicine Reports
89. Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling
    Chaoying Liu, Qun Liu, Lei Song, Yue Gu, Jing Jie, Xiaoxue Bai, Ying Yang · 2014 · Neural Regeneration Research
90. Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases
    for the Alzheimer Precision Medicine Initiative (APMI), Filippo Baldacci, Simone Lista, Sid E. O’Bryant, Roberto Ceravolo, Nicola Toschi, Harald Juergen Hampel · 2018 · Methods in molecular biology
91. O1‐04‐07: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18‐month international multi‐center phase 3 trial
    Gordon Keith Wilcock, Sandra E. Black, Alfred H. Balch, David A. Amato, Andrew Paul Beelen, Lon S. S. Schneider, Robert C. Green, Edward A. Swabb, Kenton H. Zavitz · 2009 · Alzheimer s & Dementia
92. [46] Inflammatory responses to amyloid fibrils
    Stephen L. Yates, June Kocsis‐Angle, Paula Embury, Kurt R. Brunden · 1999 · Methods in enzymology on CD-ROM/Methods in enzymology
93. NSAIDs protect neurons and preserve memory in a mouse model of AD
    Hemi A. I. Malkki · 2016 · Nature Reviews Neurology
94. The Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy
    &NA; · 2000 · Alzheimer Disease & Associated Disorders
95. Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial
    Aisen, Paul S., Schafer, Kimberly A., Grundman, Michael, Pfeiffer, Eric, Sano, Mary, Davis, Kenneth L., Farlow, Martin R., Jin, Shelia, Thomas, Ronald G., Thal, Leon J. et al. · 2003 · JAMA
96. O5‐04‐03: Regular multimodal aerobic exercise reduces pro‐inflammatory cytokines and improves BDNF peripheral levels and executive functions in elderly MCI individuals with different BDNF Val66Met genotypes
    Carla Manuela Crispim Nascimento, Márcia R. Cominetti, Jessica Rodrigues Pereira, Larissa Pires de Andrade, Marcelo Garuffi, Daniel Shikanai Kerr, Orestes Vicente Forlenza, Florindo Stella · 2015 · Alzheimer s & Dementia
97. Untitled work
    1999 · 10.1002/1531-8249(199912)46:6